Showing 1241-1250 of 3287 results for "".
Don't Shoot the Messenger
https://practicaldermatology.com/topics/practice-management/dont-shoot-the-messenger/20791/Act now to avoid a seven percent MIPS penalty in 2021.Make Some Noise: Advocating for Access
https://practicaldermatology.com/topics/practice-management/make-some-noise-advocating-for-access/20401/DCAN seeks to improve access to dermatologic treatments.Three's the Charm
https://practicaldermatology.com/topics/practice-management/threes-the-charm/20585/Expert injectors discuss the promise and perils of Botox Cosmetic's third nod.It's All About Relationships
https://practicaldermatology.com/topics/practice-management/its-all-about-relationships/20711/The Invasion of the Picoseconds
https://practicaldermatology.com/topics/practice-management/the-invasion-of-the-picoseconds/20763/Pico devices are finding their niche, with expanded applications that may make them more attractive for practices.New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-1/23302/The Next Frontier: Device-Based Erectile Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-next-frontier-device-based-erectile-rejuvenation/20828/Low-intensity cutaneous shockwave treatment represents a novel option for the treatment of vasculogenic ED.New Products
https://practicaldermatology.com/columns/new-products/new-products/20885/Medical Costs Skyrocket and New York Times Reporter Finds a Scapegoat
https://practicaldermatology.com/topics/practice-management/medical-costs-skyrocket-and-emnew-york-timesem-reporter-finds-a-scapegoat/21404/Non-genital Warts: A Review of Current Treatments
https://practicaldermatology.com/topics/general-topics/non-genital-warts-a-review-of-current-treatments/21884/When determining which treatment modality to choose for non-genital warts, there are several factors to consider, including the convenience of the treatment, patient discomfort, location of warts, and potential side effects.